Lite Strategy, Inc. (NASDAQ: LITS) has announced its financial results for the first quarter of fiscal year 2026. This marks a pivotal period driven by the implementation of its $100 million Litecoin-focused treasury strategy and the company’s shift into more active capital market operations. The company, which recently rebranded from MEI Pharma, now stands as […]
